Invesco’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.72M Sell
121,103
-2,903
-2% -$156K ﹤0.01% 2048
2025
Q4
$6.01M Buy
124,006
+81,625
+193% +$3.18M ﹤0.01% 2150
2025
Q3
$1.3M Sell
42,381
-40,793
-49% -$936K ﹤0.01% 2813
2025
Q2
$1.85M Buy
83,174
+61,838
+290% +$1.29M ﹤0.01% 2598
2025
Q1
$397K Sell
21,336
-1,952
-8% -$32.6K ﹤0.01% 3246
2024
Q4
$308K Sell
23,288
-28,002
-55% -$678K ﹤0.01% 3406
2024
Q3
$1.72M Buy
51,290
+32,380
+171% +$1.11M ﹤0.01% 2666
2024
Q2
$474K Sell
18,910
-1,165
-6% -$27.1K ﹤0.01% 3289
2024
Q1
$452K Buy
20,075
+10,357
+107% +$245K ﹤0.01% 3377
2023
Q4
$208K Sell
9,718
-304
-3% -$5.24K ﹤0.01% 3557
2023
Q3
$180K Sell
10,022
-45
-0.4% -$859 ﹤0.01% 3628
2023
Q2
$205K Buy
+10,067
New +$204K ﹤0.01% 3601
2023
Q1
Sell
-18,297
Closed -$567K 3869
2022
Q4
$567K Sell
18,297
-16
-0.1% -$452 ﹤0.01% 3204
2022
Q3
$467K Sell
18,313
-636
-3% -$14.9K ﹤0.01% 3280
2022
Q2
$384K Buy
18,949
+2,251
+13% +$49.9K ﹤0.01% 3467
2022
Q1
$413K Sell
16,698
-2,516
-13% -$76.1K ﹤0.01% 3487
2021
Q4
$668K Sell
19,214
-2,041
-10% -$64.7K ﹤0.01% 3264
2021
Q3
$576K Buy
21,255
+1,172
+6% +$29.7K ﹤0.01% 3362
2021
Q2
$521K Buy
20,083
+1,330
+7% +$31.9K ﹤0.01% 3401
2021
Q1
$404K Sell
18,753
-10,233
-35% -$258K ﹤0.01% 3428
2020
Q4
$623K Buy
28,986
+2,547
+10% +$61.9K ﹤0.01% 3130
2020
Q3
$390K Sell
26,439
-770
-3% -$13.9K ﹤0.01% 3218
2020
Q2
$608K Sell
27,209
-3,051
-10% -$55.8K ﹤0.01% 3035
2020
Q1
$427K Buy
+30,260
New +$459K ﹤0.01% 3116
2019
Q4
Sell
-341,563
Closed -$12M 3651
2019
Q3
$12M Sell
341,563
-755,899
-69% -$36M ﹤0.01% 1656
2019
Q2
$61.9M Buy
1,097,462
+1,093,095
+25,031% +$78.7M 0.02% 926
2019
Q1
$319K Buy
+4,367
New +$301K ﹤0.01% 3467
2018
Q3
Sell
-80,176
Closed -$5.7M 3887
2018
Q2
$5.7M Buy
80,176
+16,389
+26% +$1.37M ﹤0.01% 2046
2018
Q1
$6.64M Sell
63,787
-13,836
-18% -$1.56M ﹤0.01% 1783
2017
Q4
$7.82M Buy
+77,623
New +$5.71M ﹤0.01% 1717

Other funds holding ANAB